SlideShare a Scribd company logo
Preformulation Studies
Presentedby-
Name :- FARMAN AHMA
B.Pharm 5th Sem
Teerthanker Mahaveer College Of Pharmac
Content…..
Introduction.
Goals and objective of preformulation studies
Preformulation considerations
Application of Preformulation Considerations in the development
of dosage forms.
Impact of Preformulation considerations on Stability of dosage
form.
Conclusion
Introduction….
“Preformulation studies are the investigations of physical
and chemical properties of drug substance alone and in
combination with other excipients to develop a Safe
,Effective and Stable dosage form”
These are the first step in the rational development of
dosage forms of a drug substance.
It is the phase of research and development of drug
Goals and objective of preformulation studies….
• To establish the physicochemical parameters of drug molecules for
its stability for any desired dosage form.
• To determine the kinetic rate profile of a drug substance for drug
stability
• To establish compatibility of any drug with formulation excipients
for possible interactions
• Preparation of safe ,effective ,and stable dosage form with better
therapeutic values
Preformulation considerations….
Preformulation studies can be divided into-
1. Physical considerations
 Organoleptic
 Microscopic
 Particle size and shape
 Partition coefficient
 Pka
 Solubility
 Dissolution
 Polymorphism
 Physical form( crystalline/amorphous)
 Flow properties
Preformulation considerations….
2- Chemical considerations
 Hydrolysis
 Oxidation
 Reduction
 Racemization
 Polymerisation
 Isomerisation
 Photostability
Physical Considerations…
1. Physical form:-
Drug may exist in crystal or
amorphous form.
 Crystal form:-
It is characterized by repeated arrangements of atoms in
three –dimensional (3-D) array.
 Amorphous form:-
it has atoms or molecules randomly placed and does not
have any defined structure or molecular arrangement.
Physical Considerations…
2- Polymorphism:-
It is the ability of a solid material to
exist in more than one form of crystal structure.
Polymorphs may divided in to two types-
 Enantiotropic :- Reversibly changes into another form at
varying in temperature & pressure .
Example- carbamazepine ,acetozolamide .
 Monotropic:- Unstable at all temperature & pressure .
Example – flufenamic acid .
Physical Considerations…
3- Particle size:-
Particle diameter is also important
consideration in the preformulation studies.
4- Particle shape:-
Particles may exist in various shape.
Like- spherical, oval, rod-shaped etc.
Particle shape also important consideration in
preformulation studies .
Physical Considerations…
5- Flow properties:-
Flow properties of material can be measured by following
determinations.
 Angle of repose:-
The angle of repose or the critical angle of repose, of a granular material
is the steepest angle relative to the horizontal plane which a material
can be piled without slumping or the surface material sliding.
[Angle of repose (ϑ)= tan−1(2H/D)]
 Carr’s index( compressibility ):-
Carr’s index can be calculated by formula
[ C= tapped density – bulk density X100 ]
tapped density
Physical Considerations…
6- Solubility profile:-
In solubility profile following parameters are considered .
 Partition co-efficient:-
“It is the ratio of drug amount dissolved in oil phase to the drug
amount dissolved in aqueous phase”
Partition co-efficient (P) = Xo
Xw
 PKa :- it is also called dissociation constant .
This parameter gives information about drug ionization at any
physiological PH condition . It can be calculated by-
[Henderson-Hasselbalch equation pH = pKa + log([A-]/[HA])]
 PH:- it is the measurement unit of acidity or alkalinity of any
chemical compound .
Chemical Considerations…
1- Hydrolysis:-
It is the chemically breakdown reaction of any compound
in the presence of water.
2- Oxidation – Reduction (Redox) reaction:-
An oxidation-reduction (redox) reaction is a type of -
chemical reaction that involves-
 Oxidation is the gain of oxygen.
 Reduction is the loss of oxygen.
 Oxidation is the loss of hydrogen.
 Reduction is the gain of hydrogen.
 Oxidation is loss of electrons
 Reduction is gain of electrons
Chemical Considerations…
3- Racemization:-
It is the formation of racemic mixture from any optically
active compound.
 Racemic mixture is the equimolar mixture of enantiomers and
it is optically inactive.
4- polymerization:-
It is a continuous reaction between molecules , more
than one monomer reacts together to form a polymer.
Application of Preformulation Considerations in the development
of dosage forms……
All the considerations of preformulation studies are applicable to produce an
optimized and stable dosage form of any known or new drug substance.
1. Drug–excipient compatibility study:-
Excipients are the non-pharmacological substances which are
required to convert a drug into a desired dosage form.
 Excipient should be compatible with drug and should be inert,
otherwise it may produce any other chemical entity by reacting
with the drug.
 There are two methods for the assessment of drug-excipient
compatibility.
(a)D.S.C method ( digital scanning calorimeter)
(b) F.T.I.R method ( fourier transform infrared spectrometer )
Application of Preformulation Considerations in the development
of dosage forms……
2- Physical form:-
This is an important preformulation consideration related with the
drug form, is either crystalline or amorphous.
Physical form of drug may affect –
- Melting point
- Solubility
- Density
- Vapor pressure
- Compressibility
For the optimization of above factors we need to study about the physical
form of drug.
 Amorphous drugs are generally have higher solubility and less stability
as compared to crystalline drug.
Application of Preformulation Considerations in the development
of dosage forms……
3- Polymorphism:-
Due to different shape of material, arrangement of
atoms also differ that leads to vary in crystal energy.
Hence every shape of material possess different reactivity ,
that affects-
- Chemical stability
- Solubility
- Bioavailability
- Melting point
To stabilize the above factors ,we should have proper
knowledge about the phenomenon of polymorphism
Application of Preformulation Considerations in the development
of dosage forms……
4- Particle size :-
Particle size & size distribution affects-
- Dissolution rate
- Absorption rate
- Content uniformity
- Taste
- Texture
- Color
- Stability
Particle size should be optimum for every dosage form.
Application of Preformulation Considerations in the development
of dosage forms……
5- Angle of repose:-
angle of repose tells about that flow properties of
material. flow properties affect-
- Production rate
- Uniformity of dose
- Efficacy of dosage form
Angle of repose Type of flow
<20 Excellent
20-30 Good
30-34 Passable
>40 Poor flow
Application of Preformulation Considerations in the development
of dosage forms……
6- Carr’s index(compressibility) :-
it is an indication about the compressibility of material, on
the basis of Carr’s index of powder we decide the
compression methods during tablet formulation.
- Direct compression ( if powder material compressible) .
- Dry granulation
- Wet granulation
Carr’s index Type of flow
5-15 Excellent
12-16 Good
18-21 Passable
23-35 Poor
33-38 Very poor
>40 Extremely poor
Application of Preformulation Considerations in the development
of dosage forms……
7- Partition co-efficient:-
It is the measurement of hydrophilicity and lipophilicity of any drug
substance.
Hydrophilicity and lipophilicity of any drug affects its-
- Absorption through biological membrane
- Solubility in aqueous media
 If Partition co-efficient is more than one then drug is lipophilic in
nature, highly lipophilic drug may cross blood brain barrier and
blood-placental barrier.
 If partition co-efficient is less than one then drug is hydrophilic in
nature and may easily dissolve in aqueous media.
Application of Preformulation Considerations in the development
of dosage forms……
8- Pka:-
This parameter gives information about drug ionization
at any physiological PH.
 By determining the PH and Pka of any drug we can easily
predict the absorption rate of any drug at any PH.
9- Hydrolysis:-
H+ and OH- are the reactive species ,responsible for drug
hydrolysis in solutions.
 Hydrolysis is mainly considered in solutions and deal with the
drug stability during shelf life and its degradation.
Application of Preformulation Considerations in the development
of dosage forms……
10- Racemization:-
Racemization may occurs due to heat or any chemical
reaction , in which half of the optically active compound
becomes its mirror image.
Racemization may affect-
- Solubility
- Dissolution rate
- Absorption
- Bioavailability
- Drug-receptor interaction
- Pharmacological efficacy
 Hence it has to be establish that racemization does not occur under
the labeled conditions of storage until shelf life.
Impact of Preformulation considerations on Stability of dosage
form….
Preformuation considerations affect the stability of dosage
forms If they are not in optimized condition.
1-Physical form(Crystal or Amorphous):-
Crystalline form is more stable than amorphous
form because crystal has arranged internal structure.
Eg:- Crystalline Penicillin-G is more stable than amorphous form.
Tablet stability may affect due to crystal packing arrangement of
drug.
Impact of Preformulation considerations on Stability of dosage
form…
2- Polymorphism:-
polymorphism is the phenomenon of changing in shape
and size of solid material at different temperature and
pressure ,so it may cause instability in the dosage form
during storage.
 Polymorphs are also evaluated to be sure that they are not
changing their shape and size during unit operations of
formulation ,like- drying , milling etc.
Impact of Preformulation considerations on Stability of dosage
form….
3- Particle size:-
Particle size reduction less than 10u causes incorporation of
gas/air between particles ,this prevents water penetration between
particles and reduce wetting properties of particles ,which may
cause-
- Sedimentation
- Creaming
- Cracking
 Extreme size reduction increase higher surface area which may
leads to-
- Polymorphic changes
- Rapid degradation when exposed to- Air, Heat, Light, Humidity ,and
oxygen.
Larger particle size also cause instability in the formulations.
Impact of Preformulation considerations on Stability of dosage
form….
4- Carr’s Index:-
Powder material’s compressibility should be optimum otherwise
fragmentation may occur after formulation of tablet.
5- Hydrolysis :-
It mainly consider in preformuation study of solution.
 In the presence of water certain drug are degraded.
 Hydroxyl ions of water are strong nucleophiles
 In solution of the acidic PH(<7), H+ ions cause hydrolysis reactions.
 These degradation reactions are higher in alkaline solutions than in water.
 Hydrolysis is affected by the PH of solution , presence of buffer salts & co-
solvents, complexing agents & surfactants .
Impact of Preformulation considerations on Stability of dosage
form…..
6- Oxidation:-
Most common cause of drug decomposition in solutions
 It is promoted by the presence of oxygen and reaction can be
initiated by the action of heat , light or trace metal ions that
produce free radicals , these free radicals propagate the
oxidation reaction that cause drug degradation.
7- Racemization:-
Conversion of enantiomer in its mirror image may leads to
instability of drug ,because in this reaction drug’s structure is
changed that may propagate other reactions.
Impact of Preformulation considerations on Stability of dosage
form…
8- Polymerization:-
It leads to increase in viscosity of the
formulation that may cause difficulties in drug
stability during storage.
Conclusion ………..
Drug development is a very complex , Expensive and time
consuming process and there is higher risk of failure.
 To minimize the risk of failure we have to optimize
preformulation considerations.
 For optimization we should have proper knowledge about the
drug’s physicochemical properties
Hence preformulation study is the obligatory phase to
avoid loss of time and money and to develop a Safe , Effective
& Stable dosage form
Preformulation studies

More Related Content

What's hot

Tablet Coating
Tablet CoatingTablet Coating
Tablet Coating
bhanu_biswas
 
LIQUID ORALS INDUSTRIAL PHARMACY
LIQUID ORALS INDUSTRIAL PHARMACYLIQUID ORALS INDUSTRIAL PHARMACY
LIQUID ORALS INDUSTRIAL PHARMACY
RACHIT KUMAR GUPTA
 
Physical Properties of Pre-formulation.pptx
Physical Properties of Pre-formulation.pptxPhysical Properties of Pre-formulation.pptx
Physical Properties of Pre-formulation.pptx
RAHUL PAL
 
Formulation and evaluation of aerosals
Formulation and evaluation of aerosalsFormulation and evaluation of aerosals
Formulation and evaluation of aerosals
Siddu K M
 
Soft gelatin capsules
Soft gelatin capsulesSoft gelatin capsules
Soft gelatin capsules
Teny Thomas
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Rishi Ram Parajuli
 
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Heena Parveen
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosols
Virendra Vaishnav
 
TABLET COATING
TABLET COATINGTABLET COATING
TABLET COATING
Teny Thomas
 
Drug stability
Drug stabilityDrug stability
Drug stability
Mohammad Nuruzzaman
 
Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
Arpan Dhungel
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Komal Sathe
 
Pharmacognosy II as per PCI syllabus
Pharmacognosy II as per PCI syllabusPharmacognosy II as per PCI syllabus
Pharmacognosy II as per PCI syllabus
MugdhaJoshi21
 
Objectives of Preformulation
Objectives of PreformulationObjectives of Preformulation
Objectives of Preformulation
KashviDesai
 
Pelletization
PelletizationPelletization
Pelletization
kajal pradhan
 
Bioassay of oxytocin
Bioassay of oxytocinBioassay of oxytocin
Bioassay of oxytocin
Trisha Das
 
Bio assays of insulin
Bio assays of insulinBio assays of insulin
Bio assays of insulin
Syed Nayyer Alvi
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
Suneal Saini
 
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
Srinivas college of pharmacy, Mangalore
 
Equipments for Pellets
Equipments for PelletsEquipments for Pellets
Equipments for Pellets
bediaman17
 

What's hot (20)

Tablet Coating
Tablet CoatingTablet Coating
Tablet Coating
 
LIQUID ORALS INDUSTRIAL PHARMACY
LIQUID ORALS INDUSTRIAL PHARMACYLIQUID ORALS INDUSTRIAL PHARMACY
LIQUID ORALS INDUSTRIAL PHARMACY
 
Physical Properties of Pre-formulation.pptx
Physical Properties of Pre-formulation.pptxPhysical Properties of Pre-formulation.pptx
Physical Properties of Pre-formulation.pptx
 
Formulation and evaluation of aerosals
Formulation and evaluation of aerosalsFormulation and evaluation of aerosals
Formulation and evaluation of aerosals
 
Soft gelatin capsules
Soft gelatin capsulesSoft gelatin capsules
Soft gelatin capsules
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , Oxytocin
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosols
 
TABLET COATING
TABLET COATINGTABLET COATING
TABLET COATING
 
Drug stability
Drug stabilityDrug stability
Drug stability
 
Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Pharmacognosy II as per PCI syllabus
Pharmacognosy II as per PCI syllabusPharmacognosy II as per PCI syllabus
Pharmacognosy II as per PCI syllabus
 
Objectives of Preformulation
Objectives of PreformulationObjectives of Preformulation
Objectives of Preformulation
 
Pelletization
PelletizationPelletization
Pelletization
 
Bioassay of oxytocin
Bioassay of oxytocinBioassay of oxytocin
Bioassay of oxytocin
 
Bio assays of insulin
Bio assays of insulinBio assays of insulin
Bio assays of insulin
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
 
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents .Dr.U.Srinivasa, P...
 
Equipments for Pellets
Equipments for PelletsEquipments for Pellets
Equipments for Pellets
 

Similar to Preformulation studies

PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
MuungoLungwani
 
preformulation studies
preformulation studiespreformulation studies
preformulation studies
Princy Rana
 
1.preformulation concept in Modern pharmaceutics.pptx
1.preformulation concept in Modern pharmaceutics.pptx1.preformulation concept in Modern pharmaceutics.pptx
1.preformulation concept in Modern pharmaceutics.pptx
PNMallikarjun
 
Preformultion study.pptx
Preformultion study.pptxPreformultion study.pptx
Preformultion study.pptx
AbulKawsarSoikot
 
(Preformulaion works)
(Preformulaion works)(Preformulaion works)
(Preformulaion works)
Pharmacy Universe
 
Pharmaceutical Technology 1
Pharmaceutical Technology 1Pharmaceutical Technology 1
Pharmaceutical Technology 1
Touheed Ovi
 
Dosage form design
Dosage form designDosage form design
Preformulation.
Preformulation.Preformulation.
Preformulation.
Miadur rahman
 
Preformulation
PreformulationPreformulation
Preformulation
Mohammad Mahfuzul Islam
 
Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...
Kailash Vilegave
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)
Tarun Parashar
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulation
M R S
 
1. Preformulation studies AYP.pptx
1. Preformulation studies AYP.pptx1. Preformulation studies AYP.pptx
1. Preformulation studies AYP.pptx
khushalchavan
 
Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
Supriya hiremath
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
IshwariDeshmukh1
 
Preformulation Considerations MANIK
Preformulation Considerations MANIKPreformulation Considerations MANIK
Preformulation Considerations MANIK
Imran Nur Manik
 
0 preformulation (1)
0 preformulation (1)0 preformulation (1)
0 preformulation (1)
muthulakshmi623285
 
Preformulation Studies
Preformulation  StudiesPreformulation  Studies
Preformulation Studies
Naimat afridi
 
Preformulation of sterile products
Preformulation of sterile products Preformulation of sterile products
Preformulation study by Pavan B Zalte
Preformulation  study by Pavan B ZaltePreformulation  study by Pavan B Zalte
Preformulation study by Pavan B Zalte
PavanZalte2
 

Similar to Preformulation studies (20)

PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
 
preformulation studies
preformulation studiespreformulation studies
preformulation studies
 
1.preformulation concept in Modern pharmaceutics.pptx
1.preformulation concept in Modern pharmaceutics.pptx1.preformulation concept in Modern pharmaceutics.pptx
1.preformulation concept in Modern pharmaceutics.pptx
 
Preformultion study.pptx
Preformultion study.pptxPreformultion study.pptx
Preformultion study.pptx
 
(Preformulaion works)
(Preformulaion works)(Preformulaion works)
(Preformulaion works)
 
Pharmaceutical Technology 1
Pharmaceutical Technology 1Pharmaceutical Technology 1
Pharmaceutical Technology 1
 
Dosage form design
Dosage form designDosage form design
Dosage form design
 
Preformulation.
Preformulation.Preformulation.
Preformulation.
 
Preformulation
PreformulationPreformulation
Preformulation
 
Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...Preformulation stability studies, physicochemical parameters affecting prefor...
Preformulation stability studies, physicochemical parameters affecting prefor...
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulation
 
1. Preformulation studies AYP.pptx
1. Preformulation studies AYP.pptx1. Preformulation studies AYP.pptx
1. Preformulation studies AYP.pptx
 
Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
 
Preformulation Considerations MANIK
Preformulation Considerations MANIKPreformulation Considerations MANIK
Preformulation Considerations MANIK
 
0 preformulation (1)
0 preformulation (1)0 preformulation (1)
0 preformulation (1)
 
Preformulation Studies
Preformulation  StudiesPreformulation  Studies
Preformulation Studies
 
Preformulation of sterile products
Preformulation of sterile products Preformulation of sterile products
Preformulation of sterile products
 
Preformulation study by Pavan B Zalte
Preformulation  study by Pavan B ZaltePreformulation  study by Pavan B Zalte
Preformulation study by Pavan B Zalte
 

Recently uploaded

clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
sayalidalavi006
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
Dr. Mulla Adam Ali
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
Katrina Pritchard
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
paigestewart1632
 

Recently uploaded (20)

clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
 

Preformulation studies

  • 1. Preformulation Studies Presentedby- Name :- FARMAN AHMA B.Pharm 5th Sem Teerthanker Mahaveer College Of Pharmac
  • 2. Content….. Introduction. Goals and objective of preformulation studies Preformulation considerations Application of Preformulation Considerations in the development of dosage forms. Impact of Preformulation considerations on Stability of dosage form. Conclusion
  • 3. Introduction…. “Preformulation studies are the investigations of physical and chemical properties of drug substance alone and in combination with other excipients to develop a Safe ,Effective and Stable dosage form” These are the first step in the rational development of dosage forms of a drug substance. It is the phase of research and development of drug
  • 4. Goals and objective of preformulation studies…. • To establish the physicochemical parameters of drug molecules for its stability for any desired dosage form. • To determine the kinetic rate profile of a drug substance for drug stability • To establish compatibility of any drug with formulation excipients for possible interactions • Preparation of safe ,effective ,and stable dosage form with better therapeutic values
  • 5. Preformulation considerations…. Preformulation studies can be divided into- 1. Physical considerations  Organoleptic  Microscopic  Particle size and shape  Partition coefficient  Pka  Solubility  Dissolution  Polymorphism  Physical form( crystalline/amorphous)  Flow properties
  • 6. Preformulation considerations…. 2- Chemical considerations  Hydrolysis  Oxidation  Reduction  Racemization  Polymerisation  Isomerisation  Photostability
  • 7. Physical Considerations… 1. Physical form:- Drug may exist in crystal or amorphous form.  Crystal form:- It is characterized by repeated arrangements of atoms in three –dimensional (3-D) array.  Amorphous form:- it has atoms or molecules randomly placed and does not have any defined structure or molecular arrangement.
  • 8. Physical Considerations… 2- Polymorphism:- It is the ability of a solid material to exist in more than one form of crystal structure. Polymorphs may divided in to two types-  Enantiotropic :- Reversibly changes into another form at varying in temperature & pressure . Example- carbamazepine ,acetozolamide .  Monotropic:- Unstable at all temperature & pressure . Example – flufenamic acid .
  • 9. Physical Considerations… 3- Particle size:- Particle diameter is also important consideration in the preformulation studies. 4- Particle shape:- Particles may exist in various shape. Like- spherical, oval, rod-shaped etc. Particle shape also important consideration in preformulation studies .
  • 10. Physical Considerations… 5- Flow properties:- Flow properties of material can be measured by following determinations.  Angle of repose:- The angle of repose or the critical angle of repose, of a granular material is the steepest angle relative to the horizontal plane which a material can be piled without slumping or the surface material sliding. [Angle of repose (ϑ)= tan−1(2H/D)]  Carr’s index( compressibility ):- Carr’s index can be calculated by formula [ C= tapped density – bulk density X100 ] tapped density
  • 11. Physical Considerations… 6- Solubility profile:- In solubility profile following parameters are considered .  Partition co-efficient:- “It is the ratio of drug amount dissolved in oil phase to the drug amount dissolved in aqueous phase” Partition co-efficient (P) = Xo Xw  PKa :- it is also called dissociation constant . This parameter gives information about drug ionization at any physiological PH condition . It can be calculated by- [Henderson-Hasselbalch equation pH = pKa + log([A-]/[HA])]  PH:- it is the measurement unit of acidity or alkalinity of any chemical compound .
  • 12. Chemical Considerations… 1- Hydrolysis:- It is the chemically breakdown reaction of any compound in the presence of water. 2- Oxidation – Reduction (Redox) reaction:- An oxidation-reduction (redox) reaction is a type of - chemical reaction that involves-  Oxidation is the gain of oxygen.  Reduction is the loss of oxygen.  Oxidation is the loss of hydrogen.  Reduction is the gain of hydrogen.  Oxidation is loss of electrons  Reduction is gain of electrons
  • 13. Chemical Considerations… 3- Racemization:- It is the formation of racemic mixture from any optically active compound.  Racemic mixture is the equimolar mixture of enantiomers and it is optically inactive. 4- polymerization:- It is a continuous reaction between molecules , more than one monomer reacts together to form a polymer.
  • 14. Application of Preformulation Considerations in the development of dosage forms…… All the considerations of preformulation studies are applicable to produce an optimized and stable dosage form of any known or new drug substance. 1. Drug–excipient compatibility study:- Excipients are the non-pharmacological substances which are required to convert a drug into a desired dosage form.  Excipient should be compatible with drug and should be inert, otherwise it may produce any other chemical entity by reacting with the drug.  There are two methods for the assessment of drug-excipient compatibility. (a)D.S.C method ( digital scanning calorimeter) (b) F.T.I.R method ( fourier transform infrared spectrometer )
  • 15. Application of Preformulation Considerations in the development of dosage forms…… 2- Physical form:- This is an important preformulation consideration related with the drug form, is either crystalline or amorphous. Physical form of drug may affect – - Melting point - Solubility - Density - Vapor pressure - Compressibility For the optimization of above factors we need to study about the physical form of drug.  Amorphous drugs are generally have higher solubility and less stability as compared to crystalline drug.
  • 16. Application of Preformulation Considerations in the development of dosage forms…… 3- Polymorphism:- Due to different shape of material, arrangement of atoms also differ that leads to vary in crystal energy. Hence every shape of material possess different reactivity , that affects- - Chemical stability - Solubility - Bioavailability - Melting point To stabilize the above factors ,we should have proper knowledge about the phenomenon of polymorphism
  • 17. Application of Preformulation Considerations in the development of dosage forms…… 4- Particle size :- Particle size & size distribution affects- - Dissolution rate - Absorption rate - Content uniformity - Taste - Texture - Color - Stability Particle size should be optimum for every dosage form.
  • 18. Application of Preformulation Considerations in the development of dosage forms…… 5- Angle of repose:- angle of repose tells about that flow properties of material. flow properties affect- - Production rate - Uniformity of dose - Efficacy of dosage form Angle of repose Type of flow <20 Excellent 20-30 Good 30-34 Passable >40 Poor flow
  • 19. Application of Preformulation Considerations in the development of dosage forms…… 6- Carr’s index(compressibility) :- it is an indication about the compressibility of material, on the basis of Carr’s index of powder we decide the compression methods during tablet formulation. - Direct compression ( if powder material compressible) . - Dry granulation - Wet granulation Carr’s index Type of flow 5-15 Excellent 12-16 Good 18-21 Passable 23-35 Poor 33-38 Very poor >40 Extremely poor
  • 20. Application of Preformulation Considerations in the development of dosage forms…… 7- Partition co-efficient:- It is the measurement of hydrophilicity and lipophilicity of any drug substance. Hydrophilicity and lipophilicity of any drug affects its- - Absorption through biological membrane - Solubility in aqueous media  If Partition co-efficient is more than one then drug is lipophilic in nature, highly lipophilic drug may cross blood brain barrier and blood-placental barrier.  If partition co-efficient is less than one then drug is hydrophilic in nature and may easily dissolve in aqueous media.
  • 21. Application of Preformulation Considerations in the development of dosage forms…… 8- Pka:- This parameter gives information about drug ionization at any physiological PH.  By determining the PH and Pka of any drug we can easily predict the absorption rate of any drug at any PH. 9- Hydrolysis:- H+ and OH- are the reactive species ,responsible for drug hydrolysis in solutions.  Hydrolysis is mainly considered in solutions and deal with the drug stability during shelf life and its degradation.
  • 22. Application of Preformulation Considerations in the development of dosage forms…… 10- Racemization:- Racemization may occurs due to heat or any chemical reaction , in which half of the optically active compound becomes its mirror image. Racemization may affect- - Solubility - Dissolution rate - Absorption - Bioavailability - Drug-receptor interaction - Pharmacological efficacy  Hence it has to be establish that racemization does not occur under the labeled conditions of storage until shelf life.
  • 23. Impact of Preformulation considerations on Stability of dosage form…. Preformuation considerations affect the stability of dosage forms If they are not in optimized condition. 1-Physical form(Crystal or Amorphous):- Crystalline form is more stable than amorphous form because crystal has arranged internal structure. Eg:- Crystalline Penicillin-G is more stable than amorphous form. Tablet stability may affect due to crystal packing arrangement of drug.
  • 24. Impact of Preformulation considerations on Stability of dosage form… 2- Polymorphism:- polymorphism is the phenomenon of changing in shape and size of solid material at different temperature and pressure ,so it may cause instability in the dosage form during storage.  Polymorphs are also evaluated to be sure that they are not changing their shape and size during unit operations of formulation ,like- drying , milling etc.
  • 25. Impact of Preformulation considerations on Stability of dosage form…. 3- Particle size:- Particle size reduction less than 10u causes incorporation of gas/air between particles ,this prevents water penetration between particles and reduce wetting properties of particles ,which may cause- - Sedimentation - Creaming - Cracking  Extreme size reduction increase higher surface area which may leads to- - Polymorphic changes - Rapid degradation when exposed to- Air, Heat, Light, Humidity ,and oxygen. Larger particle size also cause instability in the formulations.
  • 26. Impact of Preformulation considerations on Stability of dosage form…. 4- Carr’s Index:- Powder material’s compressibility should be optimum otherwise fragmentation may occur after formulation of tablet. 5- Hydrolysis :- It mainly consider in preformuation study of solution.  In the presence of water certain drug are degraded.  Hydroxyl ions of water are strong nucleophiles  In solution of the acidic PH(<7), H+ ions cause hydrolysis reactions.  These degradation reactions are higher in alkaline solutions than in water.  Hydrolysis is affected by the PH of solution , presence of buffer salts & co- solvents, complexing agents & surfactants .
  • 27. Impact of Preformulation considerations on Stability of dosage form….. 6- Oxidation:- Most common cause of drug decomposition in solutions  It is promoted by the presence of oxygen and reaction can be initiated by the action of heat , light or trace metal ions that produce free radicals , these free radicals propagate the oxidation reaction that cause drug degradation. 7- Racemization:- Conversion of enantiomer in its mirror image may leads to instability of drug ,because in this reaction drug’s structure is changed that may propagate other reactions.
  • 28. Impact of Preformulation considerations on Stability of dosage form… 8- Polymerization:- It leads to increase in viscosity of the formulation that may cause difficulties in drug stability during storage.
  • 29. Conclusion ……….. Drug development is a very complex , Expensive and time consuming process and there is higher risk of failure.  To minimize the risk of failure we have to optimize preformulation considerations.  For optimization we should have proper knowledge about the drug’s physicochemical properties Hence preformulation study is the obligatory phase to avoid loss of time and money and to develop a Safe , Effective & Stable dosage form